J
Joyce Annichino-Bizzachi
Researcher at State University of Campinas
Publications - 8
Citations - 145
Joyce Annichino-Bizzachi is an academic researcher from State University of Campinas. The author has contributed to research in topics: Antiphospholipid syndrome & Risk factor. The author has an hindex of 4, co-authored 8 publications receiving 118 citations.
Papers
More filters
Journal ArticleDOI
Cerebral venous thrombosis: influence of risk factors and imaging findings on prognosis.
Simone Appenzeller,Carlos Borelli Zeller,Joyce Annichino-Bizzachi,Lilian Tereza Lavras Costallat,Leonardo Deus-Silva,Barbara Voetsch,Andreia V. Faria,Verônica A. Zanardi,Benito Pereira Damasceno,Fernando Cendes +9 more
TL;DR: MRI is superior to conventional CT for diagnosing CVT and patients with parenchymal lesions, thrombophilia and antiphospholipid syndrome had greater risk to be left with neurological sequelae.
Journal ArticleDOI
Recurrent thrombosis in antiphospholipid syndrome may be associated with cardiovascular risk factors and inflammatory response.
Sabrina da Silva Saraiva,Isadora Custódio,Bruna M Mazetto,Marina Pereira Collela,Erich Vinicius De Paula,Simone Appenzeller,Joyce Annichino-Bizzachi,Fernanda Andrade Orsi +7 more
TL;DR: The results suggest that arterial hypertension and monocyte counts may be independent factors for thrombosis recurrence in APS, and may support the evaluation of therapeutic measures to a rigid control of blood pressures and modulation of inflammatory response in APs, as additional prophylaxis against the recurrence of vascular events.
Book ChapterDOI
Use of Platelet-Rich Plasma (PRP) in Treating Chronic Wounds
André M. Cancela,José Fábio Santos Duarte Lana,Joyce Annichino-Bizzachi,William Dias Belangero,Ângela Cristina Malheiros Luzo +4 more
TL;DR: Platelet-leukocyte gel (L-PRP), besides releasing the growth factors that start tissue regeneration, can also strengthen the antimicrobial activity, which shows its potential as an infection prevention and treatment agent.
Journal ArticleDOI
Circulating levels of tissue factor and the risk of thrombosis associated with antiphospholipid syndrome.
Laís Quinteiro Tobaldini,Fernanda Talge Arantes,Sabrina da Silva Saraiva,Bruna M Mazetto,Marina Pereira Colella,Erich Vinicius De Paula,Joyce Annichino-Bizzachi,Fernanda Andrade Orsi +7 more
TL;DR: Circulating TF is associated with thrombotic complications related to APS, but not with the risk of unprovoked VTE, as compared with controls.
Journal ArticleDOI
Acquired thrombotic thrombocytopenic purpura due to antibody-mediated ADAMTS13 deficiency precipitated by a localized Castleman's disease: a case report.
Thais Celi Lopes Benevides,Fernanda Andrade Orsi,Marina Pereira Colella,Priscila de Oliveira Percout,Muriel Silva Moura,Maria Almeida Dias,Betina Diniz Lins,Erich Vinicius De Paula,José Vassallo,Joyce Annichino-Bizzachi +9 more
TL;DR: A case of refractory TTP precipitated by a newly diagnosed localized Castleman’s disease (CD) and the antibody to ADAMTS13 developed along with the systemic manifestation of CD and promptly disappeared after the resection of the tumor.